{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:14:23Z","timestamp":1790421263810,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000142","name":"Soci\u00e9t\u00e9 de Pathologie Infectieuse de Langue Fran\u00e7aise (SPILF)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000142","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.ijantimicag.2015.08.013","type":"journal-article","created":{"date-parts":[[2015,10,2]],"date-time":"2015-10-02T02:17:25Z","timestamp":1443752245000},"page":"707-712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Carbapenem use in French hospitals: A nationwide survey at the patient level"],"prefix":"10.1016","volume":"46","author":[{"given":"R\u00e9my","family":"Gauzit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Pean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Alfandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Bru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Bedos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Rabaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9380-0570","authenticated-orcid":false,"given":"J\u00e9r\u00f4me","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2015.08.013_bib0080","series-title":"Antimicrobial resistance surveillance in Europe 2012","author":"European Centre for Disease Prevention and Control","year":"2013"},{"key":"10.1016\/j.ijantimicag.2015.08.013_bib0085","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/jac\/dks429","article-title":"10-Fold increase (2006\u201311) in the rate of healthy subjects with extended-spectrum \u03b2-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre","volume":"68","author":"Nicolas-Chanoine","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.08.013_bib0090","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1128\/AAC.01823-12","article-title":"Emergence of imipenem-resistant Gram-negative bacilli in intestinal flora of intensive care patients","volume":"57","author":"Armand-Lef\u00e8vre","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.08.013_bib0095","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1473-3099(13)70190-7","article-title":"Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases","volume":"13","author":"Munoz-Price","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.08.013_bib0100","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1093\/jac\/dkr571","article-title":"Point prevalence survey of antibiotic use in French hospitals in 2009","volume":"67","author":"Robert","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.08.013_bib0105","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1056\/NEJMoa1411162","article-title":"Trial of short-course antimicrobial therapy for intraabdominal infection","volume":"372","author":"Sawyer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2015.08.013_bib0110","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/cid\/civ121","article-title":"Predictive value of prior colonization and antibiotic use for third-generation cephalosporin-resistant Enterobacteriaceae bacteremia in patients with sepsis","volume":"60","author":"Rottier","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.08.013_bib0115","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s00134-012-2675-0","article-title":"Clinical impact and risk factors for colonization with extended-spectrum \u03b2-lactamase-producing bacteria in the intensive care unit","volume":"38","author":"Razazi","year":"2012","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2015.08.013_bib0120","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ajic.2012.03.035","article-title":"Risk associated with a systematic search of extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae","volume":"41","author":"Prinapori","year":"2013","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ijantimicag.2015.08.013_bib0125","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s10096-013-1918-5","article-title":"Impact of a program combining pre-authorization requirement and post-prescription review of carbapenems: an interrupted time-series analysis","volume":"32","author":"Delory","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.08.013_bib0130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/cid\/cir790","article-title":"\u03b2-Lactam\/\u03b2-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum \u03b2-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts","volume":"54","author":"Rodr\u00edguez-Ba\u00f1o","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.08.013_bib0135","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/jac\/dks301","article-title":"Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum \u03b2-lactamases: a systematic review and meta-analysis","volume":"67","author":"Vardakas","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.08.013_bib0140","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1128\/AAC.01523-12","article-title":"Appropriateness of empirical treatment and outcome in bacteremia caused by extended-spectrum-\u03b2-lactamase-producing bacteria","volume":"57","author":"Frakking","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.08.013_bib0145","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1128\/AAC.00135-13","article-title":"Impact of the MIC of piperacillin\u2013tazobactam on the outcome of patients with bacteremia due to extended-spectrum-\u03b2-lactamase-producing Escherichia coli","volume":"57","author":"Retamar","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.08.013_bib0150","article-title":"Elaboration of a consensual definition of de-escalation allowing a ranking of \u03b2-lactams","volume":"21","author":"Weiss","year":"2015","journal-title":"Clin Microbiol Infect"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915003209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915003209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T20:29:41Z","timestamp":1537302581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857915003209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0924857915003209"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.08.013","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carbapenem use in French hospitals: A nationwide survey at the patient level","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}